| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/10/2013 | CN102070135B Amphiphilic porous hollow carbon microsphere as well as preparation method and application thereof |
| 04/10/2013 | CN102058602B Stable oral solid preparation containing losartan potassium and hydrochlorothiazide |
| 04/10/2013 | CN102028936B Method for preparing oral protein medicament |
| 04/10/2013 | CN101953889B Compound ceftiofur suspension emulsion injection and preparation method thereof |
| 04/10/2013 | CN101909655B Method of delivering an anti-cancer agent to a cell |
| 04/10/2013 | CN101879147B Lornoxicam hydrogel patch and preparation method thereof |
| 04/10/2013 | CN101862454B Physical cross-linking hydrogel composition and preparation method and application thereof |
| 04/10/2013 | CN101837006B Application of PCL-PEG-PCL tri-block copolymer in preparation of medical anti-blocking material |
| 04/10/2013 | CN101721407B Compound articaine hydrochloride injection and preparation method thereof |
| 04/10/2013 | CN101664385B Ibutilide fumarate injection and preparation method thereof |
| 04/10/2013 | CN101579312B Teniposide liposome and preparation method thereof |
| 04/10/2013 | CN101553215B Stable and ready-to-use oil-in-water propofol microemulsion |
| 04/10/2013 | CN101516404B Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
| 04/10/2013 | CN101502553B Rhizoma atractylodis total terpene alcohol solid dispersoid, medicament composition and preparation method thereof |
| 04/10/2013 | CN101415730B Compositions and methods of use for antibodies of c-Met |
| 04/10/2013 | CN101410103B 固体药物制剂 The solid pharmaceutical preparation |
| 04/10/2013 | CN101227886B Gelatin-containing topical composition |
| 04/10/2013 | CN101084008B Therapeutic formulations of keratinocyte growth factor |
| 04/09/2013 | US8415401 Oral pharmaceutical dosage forms |
| 04/09/2013 | US8415400 Synthesizing an amphiphilic block polymer micelle having ionically-charged polymeric segments and nonionically-charged polymeric segments; neutralizing under conditions that allow for self-assembly of polymer micelles; crosslinking; removing the moieties of opposite charge; drug delivery; stability |
| 04/09/2013 | US8415389 first component containing flavonoids from green tea and second component solvent system has water and surfactant are maintained separately and are mixed prior to use; stable and ability to penetrate the skin; topical dermatological skin inflammation, wound healing, antioxidant effect, skin disorders |
| 04/09/2013 | US8415329 Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
| 04/09/2013 | US8415300 Sustained release of microcrystalline peptide suspensions |
| 04/09/2013 | US8414916 Chewable soft capsule |
| 04/09/2013 | US8414913 Edible compositions for lowering cholesterol |
| 04/09/2013 | US8414906 Additives and products including oligoesters |
| 04/09/2013 | US8414905 Film coating compositions based on polyvinyl alcohol-polyether graft copolymer/polyvinyl alcohol combinations with an improved moisture barrier effect |
| 04/09/2013 | US8414899 Vaccines comprising multimeric HSP60 peptide carriers |
| 04/09/2013 | US8414892 Uses of monoclonal antibody 8H9 |
| 04/09/2013 | CA2749172C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 04/09/2013 | CA2695605C Pyrazolone derivative emulsion formulations |
| 04/09/2013 | CA2677041C Multimeric conjugate |
| 04/09/2013 | CA2651604C Method for preparation of substantially amorphous telmisartan |
| 04/09/2013 | CA2562771C Anti-il-9 antibody formulations and uses thereof |
| 04/09/2013 | CA2457030C Devices including protein matrix materials and methods of making and using same |
| 04/09/2013 | CA2446929C Orally administering parathyroid hormone and calcitonin |
| 04/09/2013 | CA2399219C Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/04/2013 | WO2013049539A1 A method of blocking or trapping allergens |
| 04/04/2013 | WO2013049538A1 Allergen nasal compositions |
| 04/04/2013 | WO2013049405A1 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers |
| 04/04/2013 | WO2013049328A1 Di-aliphatic substituted pegylated lipids |
| 04/04/2013 | WO2013049300A1 Method of treating mucoepidermoid carcinoma |
| 04/04/2013 | WO2013049247A1 Fusion proteins for treating metabolic disorders |
| 04/04/2013 | WO2013048345A1 Methods and pharmaceutical compositions for treating cancer |
| 04/04/2013 | WO2013047946A1 Bab-type tri-block copolymer comprising polylactic acid (a) and polyethylene glycol (b), method for producing same, and drug delivery system using same |
| 04/04/2013 | WO2013047802A1 Cooling sheet for attaching to clothing |
| 04/04/2013 | WO2013047795A1 Granular pharmaceutical composition |
| 04/04/2013 | WO2013047410A1 Long-acting adhesive skin patch for treating alzheimer's disease, and method for producing same |
| 04/04/2013 | WO2013047376A1 Seamless capsule and manufacturing method therefor |
| 04/04/2013 | WO2013047373A1 Aqueous formulation containing chlorite |
| 04/04/2013 | WO2013047353A1 Orally disintegrating tablet containing hydroxyalkyl cellulose fine particles |
| 04/04/2013 | WO2013047263A1 Hemoglobin-containing liposome and method for producing same |
| 04/04/2013 | WO2013046478A1 Granule and coated granulate |
| 04/04/2013 | WO2013046453A1 Easy-to-take solid preparation |
| 04/04/2013 | WO2013046335A1 Non-aqueous patch |
| 04/04/2013 | WO2013046163A1 Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents |
| 04/04/2013 | WO2013045729A1 Cyclodextrin nanogels |
| 04/04/2013 | WO2013045455A1 Spray system for production of a matrix formed in situ |
| 04/04/2013 | WO2013045365A1 Formulations based on solid dispersions |
| 04/04/2013 | WO2013045125A1 Immunocytokine combination therapy |
| 04/04/2013 | WO2013044789A1 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
| 04/04/2013 | WO2013044788A1 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
| 04/04/2013 | WO2013044734A1 Bone targeted liposome and preparation method therefor |
| 04/04/2013 | WO2013012683A3 Gel vaccine delivery system for treating poultry |
| 04/04/2013 | WO2013009790A3 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
| 04/04/2013 | WO2012174555A3 Composition and method for stabilization and delivery of therapeutic molecules |
| 04/04/2013 | WO2012171024A3 Enzyme directed assembly of particle theranostics |
| 04/04/2013 | WO2012138694A3 Compositions comprising saccharide binding moieties and methods for targeted therapy |
| 04/04/2013 | WO2012042371A3 Pharmaceutical composition |
| 04/04/2013 | WO2011068872A8 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 04/04/2013 | US20130085267 Stabilization of Therapeutic Agents to Facilitate Administration |
| 04/04/2013 | US20130085259 Method and carrier complexes for delivering molecules to cells |
| 04/04/2013 | US20130085185 Controlled hydrolysis of poly-4-hydroxybutyrate and copolymers |
| 04/04/2013 | US20130085146 Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymphoid tissues |
| 04/04/2013 | US20130084312 Nanoparticles for delivery of bioactive agents |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | US20130084274 Liquid, Aqueous Pharmaceutical Compositions of Factor VII Polypeptides |
| 04/04/2013 | US20130084265 Delivery system for biological component |
| 04/04/2013 | US20130084261 Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery |
| 04/04/2013 | US20130084252 Use of certain neoflavonoids for intensifying and/or producing a sensory impression of sweetness |
| 04/04/2013 | US20130084250 Preparation |
| 04/04/2013 | CA2850253A1 Spray system for production of a matrix formed in situ |
| 04/04/2013 | CA2850198A1 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers |
| 04/04/2013 | CA2850024A1 Non-aqueous patch |
| 04/04/2013 | CA2849476A1 Di-aliphatic substituted pegylated lipids |
| 04/04/2013 | CA2849464A1 Fusion proteins for treating metabolic disorders |
| 04/04/2013 | CA2849033A1 Immunocytokine combination therapy |
| 04/04/2013 | CA2848065A1 Method of treating mucoepidermoid carcinoma |
| 04/04/2013 | CA2847800A1 Formulations based on solid dispersions |
| 04/04/2013 | CA2847614A1 Easily dosable solid preparation |
| 04/03/2013 | EP2574671A1 Antagonists of ligands and uses thereof |
| 04/03/2013 | EP2574343A1 Compound for skin application and use of same |
| 04/03/2013 | EP2574337A1 Carotenoid-containing composition and production method therefor |
| 04/03/2013 | EP2574168A2 Topical formulation for a jak inhibitor |
| 04/03/2013 | CN1972676B Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN103025876A Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
| 04/03/2013 | CN103025358A Factor viia complex using an immunoglobulin fragment |
| 04/03/2013 | CN103025357A Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |